文献速递心脑血管急症重症综合管理与镇静镇痛

P53抑制剂Pifithrin-μ在大鼠心脏骤停模型中的神经保护作用

Neuroprotection with the P53-Inhibitor Pifithrin-μ after Cardiac Arrest in a Rodent Model.
PubMed 文献 · Shock · 2018-01-01
一句话结论大鼠心脏骤停后给予Pifithrin-μ可减少海马CA1区变性神经元25%,但神经行为学测试无显著差异。

该研究在109只经历8或10分钟心脏骤停并复苏的大鼠中,随机给予Pifithrin-μ或对照,用组织学(FJB、CV染色)和神经行为学测试评估海马CA1区神经元损伤。Pifithrin-μ使FJB阳性变性神经元减少25%(混合ANOVA组间P=0.014),8分钟骤停组Pifithrin-μ 94±47 vs 对照128±37(每组n=11),10分钟骤停组Pifithrin-μ 78±44(n=15)vs 对照101±31(n=18),组别与骤停时长交互作用P=0.622。CV阳性缺血神经元减少未达统计学显著(ANOVA组间P=0.063),神经行为学测试各组间无显著差异。结论认为Pifithrin-μ可减少海马CA1区损伤神经元,但无临床对应表现。

要点

  • 大鼠心脏骤停后给予Pifithrin-μ使海马CA1区FJB阳性变性神经元减少25%(混合ANOVA组间P=0.014)。
  • 8分钟骤停组:Pifithrin-μ 94±47 vs 对照128±37(每组n=11);10分钟骤停组:Pifithrin-μ 78±44(n=15)vs 对照101±31(n=18)。
  • CV阳性缺血神经元减少未达统计学显著(ANOVA组间P=0.063)。
  • 神经行为学测试(Open Field Task、Tape-Removal Test、Morris Water Maze)各组间无显著差异。
  • 作者结论:Pifithrin-μ减少海马CA1区损伤神经元但无临床对应表现,需进一步研究不同设置和更长骤停时间下的作用。

适用人群与场景

  • 经历8或10分钟心脏骤停并复苏的大鼠(共109只,两个随机对照系列)。

处置流程与药物剂量

  • Pifithrin-μ或对照在心脏骤停复苏后给药(原文未写明具体剂量、途径、频次)。

研究设计与关键结果

  • 研究设计:两个随机对照系列,109只大鼠,心脏骤停8或10分钟后复苏,给予Pifithrin-μ或对照,盲法评估海马CA1区组织学(FJB、CV)及神经行为学测试。
  • 主要结果:Pifithrin-μ使FJB阳性变性神经元减少25%(混合ANOVA组间P=0.014)。
  • 8分钟骤停:Pifithrin-μ 94±47 vs 对照128±37(每组n=11);10分钟骤停:Pifithrin-μ 78±44(n=15)vs 对照101±31(n=18);组别与骤停时长交互作用P=0.622。
  • CV阳性缺血神经元减少未达统计学显著(ANOVA组间P=0.063)。
  • 神经行为学测试各组间无显著差异。

证据类型、等级与局限

  • 证据类型:动物实验(大鼠心脏骤停模型),两个随机对照系列。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为Pifithrin-μ减少海马CA1区损伤神经元但无临床对应表现,需进一步研究不同设置和更长骤停时间下的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The small molecule pifithrin-μ reversibility inhibits the mitochondrial pathway of apoptosis. The neuronal effects of pifithrin-μ applied after cardiac arrest are unknown. We hypothesized that pifithrin-μ reduces neuronal damage in the most vulnerable brain region, the hippocampus, after cardiac arrest.

METHODS: In two randomized controlled series we administered pifithrin-μ or control in 109 rats resuscitated after 8 or 10 min of cardiac arrest. Neuronal damage was blindly assessed with histology (Fluoro Jade B: FJB, cresyl violet: CV) in the most vulnerable brain region (CA1 segment of hippocampus) and with a series of neurobehavioral tests (Open Field Task, Tape-Removal Test, Morris Water Maze test). Mixed ANOVA was used to combine both series, simple comparisons were done with t tests or Mann-Whitney U test.

RESULTS: Pifithrin-μ reduced the number of degenerating, FJB-positive neurons by 25% (mixed ANOVA p group = 0.014). This was more prominent after 8 min cardiac arrest (8 min arrest pifithrin-μ 94 ± 47 vs control 128 ± 37; n = 11 each; 10 min arrest pifithrin-μ 78 ± 44, n = 15 vs control 101 ± 31, n = 18; p group* arrest length interaction = 0.622). The reduction of ischemic CV-positive neurons in pifithrin-μ animals was not significant (ANOVA p group = 0.063). No significant group differences were found in neurobehavioral testing.

CONCLUSION: Temporarily inhibition of apoptosis with pifithrin-μ after cardiac arrest decreases the number of injured neurons in the CA1 segment of hippocampus in a cardiac arrest rat model, without clinical correlate. Further studies should elucidate the role of this neuroprotective agent in different settings and with longer cardiac arrest.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Glas M, Frick T, Springe D, et al. Neuroprotection with the P53-Inhibitor Pifithrin-μ after Cardiac Arrest in a Rodent Model. Shock. 2018. PMID: 28562478. doi:10.1097/SHK.0000000000000917

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。